In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450IA2, 2D6, 2E1, and 3A4/5 phenotypes

University of Arkansas at Little Rock, Little Rock, Arkansas, United States
Clinical Pharmacology &#38 Therapeutics (Impact Factor: 7.39). 06/2005; 77(5):415-26. DOI: 10.1016/j.clpt.2005.01.009
Source: PubMed

ABSTRACT Phytochemical-mediated modulation of cytochrome P450 (CYP) activity may underlie many herb-drug interactions. Single-time point phenotypic metabolic ratios were used to determine whether long-term supplementation of goldenseal ( Hydrastis canadensis ), black cohosh ( Cimicifuga racemosa ), kava kava ( Piper methysticum ), or valerian ( Valeriana officinalis ) extracts affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4/5 activity.
Twelve healthy volunteers (6 women) were randomly assigned to receive goldenseal, black cohosh, kava kava, or valerian for 28 days. For each subject, a 30-day washout period was interposed between each supplementation phase. Probe drug cocktails of midazolam and caffeine, followed 24 hours later by chlorzoxazone and debrisoquin (INN, debrisoquine), were administered before (baseline) and at the end of supplementation. Presupplementation and postsupplementation phenotypic trait measurements were determined for CYP3A4/5, CYP1A2, CYP2E1, and CYP2D6 by use of 1-hydroxymidazolam/midazolam serum ratios (1-hour sample), paraxanthine/caffeine serum ratios (6-hour sample), 6-hydroxychlorzoxazone/chlorzoxazone serum ratios (2-hour sample), and debrisoquin urinary recovery ratios (8-hour collection), respectively. The content of purported "active" phytochemicals was determined for each supplement.
Comparisons of presupplementation and postsupplementation phenotypic ratio means revealed significant inhibition (approximately 40%) of CYP2D6 (difference, -0.228; 95% confidence interval [CI], -0.268 to -0.188) and CYP3A4/5 (difference, -1.501; 95% CI, -1.840 to -1.163) activity for goldenseal. Kava produced significant reductions (approximately 40%) in CYP2E1 only (difference, -0.192; 95% CI, -0.325 to -0.060). Black cohosh also exhibited statistically significant inhibition of CYP2D6 (difference, -0.046; 95% CI, -0.085 to -0.007), but the magnitude of the effect (approximately 7%) did not appear to be clinically relevant. No significant changes in phenotypic ratios were observed for valerian.
Botanical supplements containing goldenseal strongly inhibited CYP2D6 and CYP3A4/5 activity in vivo, whereas kava inhibited CYP2E1 and black cohosh weakly inhibited CYP2D6. Accordingly, serious adverse interactions may result from the concomitant ingestion of goldenseal supplements and drugs that are CYP2D6 and CYP3A4/5 substrates. Kava kava and black cohosh may interact with CYP2E1 and CYP2D6 substrates, respectively. Valerian appears to be less likely to produce CYP-mediated herb-drug interactions.

Download full-text


Available from: Bill Gurley, Sep 24, 2014
  • Source
    • "In contrast, one in vivo study demonstrated inhibition of CYP1A2 (Russmann et al., 2005), whereas another one detected inhibition only for CYP2E1 but not for CYP1A2, CYP2D6, and CYP3A4 (Gurley et al., 2005). These contradictory results substantiate the fact that the extrapolation of in vitro results on the in vivo situation always remains speculative. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Root extracts from kava-kava (Piper methysticum G. Forst) are clinically used for the treatment of anxiety and restlessness. Due to reported cases of liver toxicity, kava-kava extracts were withdrawn from the market in several countries in 2002. Because the efflux transporter P-glycoprotein (P-gp) is involved in the absorption, distribution, and excretion of many drugs and often participates in drug-drug interactions, we studied the effect of a crude kava extract and the main kavalactones kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin on the P-gp-mediated efflux of calcein-acetoxymethylester in the P-gp-overexpressing cell line P388/dx and the corresponding cell line P388. The crude extract and the kavalactones showed a moderate to potent inhibitory activity with f2) (concentration needed to double baseline fluorescence) values of 170 microg/ml and 17 to 90 microM, respectively. The f2 value of yangonin could not be determined due to its higher lipophilicity. In conclusion, our results for the first time demonstrate P-gp-inhibitory activity of kava-kava and its components in vitro.
    Drug Metabolism and Disposition 12/2005; 33(11):1580-3. DOI:10.1124/dmd.105.005892 · 3.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The current information on herb-drug interactions is compelling. Avoiding potential or negative interac- tions is essential to patient safety, and understanding which herb-drug combinations work synergistically may improve clinical outcomes. Botanical medicines account for approximately 22% of all complementary and alter- native medicine (CAM) therapies. 1 A 1997 survey found that up to 70% of all Americans take herbal products, and 18.4% of people on prescription medications com- bine them with herbs and/or vitamins. 2 Clearly, it is nec- essary for clinicians to have a working knowledge of herb-drug interactions. Many clinicians are unfamiliar with this subject, however. In 2000, a survey administered at 3 educational meetings on emergency and internal medicine in Orange and Los Angeles counties, Calif., showed that participat- ing doctors and students had "little familiarity with herbal toxicities and herb-drug interactions." 3 Furthermore, they rated their knowledge of this subject as poor. This article reviews potential and known herb-drug interactions and provides information to help clinicians estimate the rela- tive risk of herb-drug interactions. MECHANISMS OF INTERACTIONS Herb-drug interactions follow the same principles as drug-drug interactions. They can be of 2 primary types: pharmacodynamic and pharmacokinetic. Pharmacodynamic interactions relate to the mechanism of action, whereas pharmacokinetics have to do with the absorption, distribution, and elimination of drugs, herbs, and other chemicals. Additionally, concomitant administration of herbs and drugs may decrease the absorption of bioactive compounds by altering the local pH or by binding the compounds in the intestinal lumen and preventing their uptake by enterocytes.
Show more

Similar Publications